| Weight | 365.98 g/mol |
|---|---|
| Formula | C7H18NO8Sb |
| Hydrogen Acceptors | 8 |
| Hydrogen Donors | 7 |
| Aromatic Rings | 0 |
| Rotatable Bonds | 6 |
Glucantime (133-51-7)
meglumine antimoniate · N-methylglucamine antimonate
Score:
#574 in Microbiology
,
#4627 in Biology
,
#5871 in Chemistry
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for Glucantime
- Fisher Scientific - Search for Glucantime
- TCI - Search for Glucantime
- In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. (Antimicrobial Agents and Chemotherapy, 1997)
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites (PLOS Medicine, 2006)
- Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate. (American Journal of Tropical Medicine and Hygiene, 2001)
- Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. (Veterinary Parasitology, 1999)
- Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate (Transactions of The Royal Society of Tropical Medicine and Hygiene, 1988)
- Treatment of visceral leishmaniasis in HIV-infected patients : a randomized trial comparing meglumine antimoniate with amphotericin B (AIDS, 1999)
-
Predict GHS Hazards for Any Chemical in silico.
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. - meglumine antimoniate
- N-methylglucamine antimonate
-
SMILESCNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O
-
InChIKeyXOGYVDXPYVPAAQ-UHFFFAOYSA-M
- Pubchem - Glucantime
- Wikipedia - meglumine antimoniate
Meglumine antimoniate is a medicine used to treat leishmaniasis. This includes visceral, mucocutaneous, and cutaneous leishmaniasis. It is given by injection into a muscle or into the area infected.
Suppliers
Most-cited Publications
Areas of Application
Safety
Alternate Names
External Links
Similar Compounds
N-Methyl-D-glucamine
(6284-40-8)
3 alternate names
3 suppliers
meglumine
(6284-40-8)
3 alternate names
3 suppliers
D-manno-Heptulose
(29325-35-7, 3019-74-7, 3615-44-9)
3 alternate names
3 suppliers
Gallic acid
(149-91-7)
3 alternate names
3 suppliers
inositol 1-phosphate
(15421-51-9, 2831-74-5, 573-35-3)
3 alternate names
3 suppliers
d-iduronic acid
(3402-98-0)
3 alternate names
3 suppliers
1,2,3,4-BUTANETETRACARBOXYLIC ACID
(1703-58-8)
3 alternate names
3 suppliers
Ins6P
(15421-51-9, 21667-10-7, 46495-39-0)
3 alternate names
3 suppliers
Inositol 3-phosphate
(2831-74-5, 573-35-3)
3 alternate names
3 suppliers
endothall
(28874-46-6, 145-73-3)
3 alternate names
5 safety hazards
3 suppliers
UNII-18F7018HG1
(28871-63-8)
3 alternate names
3 suppliers
carboplatin
(41575-94-4)
3 alternate names
3 suppliers
134-03-2
(134-03-2)
3 alternate names
3 suppliers
carboplatin
(41575-94-4)
3 alternate names
3 suppliers
SODIUM ERYTHORBATE
(7378-23-6, 6381-77-7)
3 alternate names
3 suppliers
D-(+)-Glucosamine hydrochloride
(3416-24-8)
3 alternate names
3 suppliers
41575-94-4
(41575-94-4)
3 alternate names
3 suppliers
cis-Aconitic acid
(585-84-2, 499-12-7)
3 alternate names
3 suppliers
shikimic acid
(138-59-0)
3 alternate names
3 suppliers
2-Aminohexanedioic acid
(542-32-5)
3 alternate names
3 suppliers
1,5-Anhydro-D-glucitol
(154-58-5)
3 alternate names
3 suppliers
trans-Aconitic acid
(499-12-7, 4023-65-8)
3 alternate names
3 suppliers
1,6-Anhydro-beta-D-glucopyranose
(498-07-7)
3 alternate names
3 suppliers
D-Isoglucosamine
(4429-04-3)
3 alternate names
3 suppliers
Leucoglucosan
(498-07-7)
3 alternate names
3 suppliers
2,6-Diiodo-4-nitrophenol
(305-85-1)
3 alternate names
3 suppliers
Tris(2-carboxyethyl)phosphine
(5961-85-3, 115-96-8)
3 alternate names
3 suppliers
CYSTEAMINE BITARTRATE
(27761-19-9)
3 alternate names
3 suppliers
CAS Directory
